Medicare Enrolled
Dr. Lisa Cabrera, MD
Nephrology · San Antonio, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cabrera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cabrera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cabrera
Dr. Lisa Cabrera is a nephrology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cabrera performed 3,811 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cabrera received a total of $10,305 from 42 pharmaceutical and/or device companies across 423 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cabrera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in TX
$10,305 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,811
Medicare services
Top 8% in TX for nephrology
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,282 | $6 | $60 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
568 | $45 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
382 | $58 | $237 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
220 | $30 | $75 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
208 | $261 | $650 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
206 | $36 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
177 | $10 | $26 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
148 | $89 | $200 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
135 | $2 | $7 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
118 | $37 | $93 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
116 | $213 | $538 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
105 | $37 | $118 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
61 | $61 | $140 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $123 | $390 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
28 | $145 | $513 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
12 | $224 | $539 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
11 | $7 | $43 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,305
Total received (2018-2024)
Avg $1,472/year across 7 years
Top 9% in TX for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
423
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,650
2023
$2,275
2022
$1,673
2021
$1,771
2020
$410
2019
$908
2018
$618
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$654
Fresenius USA Marketing, Inc.
$269
Amgen Inc.
$225
Lilly USA, LLC
$214
VentureMed Group, Inc.
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
Aurinia Pharma U.S., Inc.
$133
OPKO Pharmaceuticals, LLC
$131
Travere Therapeutics, Inc.
$109
Bayer Healthcare Pharmaceuticals Inc.
$90
CALLIDITAS THERAPEUTICS US INC.
$81
Merck Sharp & Dohme LLC
$79
Ardelyx, Inc.
$67
Medtronic, Inc.
$58
Novartis Pharmaceuticals Corporation
$50
CorMedix Inc.
$41
Novo Nordisk Inc
$40
Daiichi Sankyo Inc.
$35
ANI Pharmaceuticals, Inc.
$31
AKEBIA THERAPEUTICS INC
$25
Kyowa Kirin, Inc.
$15
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,950
Fresenius USA Marketing, Inc.
$1,325
OPKO Pharmaceuticals, LLC
$751
Medtronic, Inc.
$568
Amgen Inc.
$516
GlaxoSmithKline, LLC.
$444
Daiichi Sankyo Inc.
$349
Otsuka America Pharmaceutical, Inc.
$347
Lilly USA, LLC
$337
Aurinia Pharma U.S., Inc.
$319
Bayer Healthcare Pharmaceuticals Inc.
$285
Bayer HealthCare Pharmaceuticals Inc.
$278
FRESENIUS USA INC.
$250
Horizon Therapeutics plc
$246
Travere Therapeutics, Inc.
$222
Novo Nordisk Inc
$213
Boehringer Ingelheim Pharmaceuticals, Inc.
$192
Vifor Pharma, Inc.
$167
AKEBIA THERAPEUTICS INC
$163
VentureMed Group, Inc.
$153
NxStage Medical, Inc.
$151
Mallinckrodt Hospital Products Inc.
$142
CALLIDITAS THERAPEUTICS US INC.
$135
Ardelyx, Inc.
$91
Keryx Biopharmaceuticals, Inc.
$81
Alexion Pharmaceuticals, Inc.
$81
Merck Sharp & Dohme LLC
$79
Novartis Pharmaceuticals Corporation
$71
Relypsa, Inc.
$54
ANI Pharmaceuticals, Inc.
$49
Kyowa Kirin, Inc.
$42
Allergan, Inc.
$41
CorMedix Inc.
$41
Tactile Systems Technology Inc
$34
Allergan Inc.
$25
Mallinckrodt Enterprises LLC
$20
Ultragenyx Pharmaceutical Inc.
$17
Boston Scientific Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Calliditas Therapeutics US Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$13
Retrophin, Inc.
$13
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ABRE · ACTHAR · AURYXIA · Amitiza · Auryxia · BENLYSTA · BRILINTA · BYSTOLIC · Crysvita · DefenCath · Dialyzers · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · Edarbi · FARXIGA · FLEX Vessel Prep System · FLEXITOUCH · Fabhalta · Flexitouch Plus · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIBERTY SELECT CYCLER · LINZESS · LOKELMA · LUPKYNIS · LUX-Dx Insertable Cardiac Monitor · MOUNJARO · NXSTAGE SYSTEM ONE · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Rybelsus · SOLIRIS · TARPEYO · TAVNEOS · TRULICITY · VERQUVO · Vafseo · Velphoro · Veltassa
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
100
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SAN ANTONIO STATE HOSP STATE SCHOOL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cabrera is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cabrera experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. Cabrera performed 1,282 epoetin alfa injection (procrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cabrera receive payments from pharmaceutical companies?
Yes. Dr. Cabrera received a total of $10,305 from 42 companies across 423 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cabrera's costs compare to other nephrologists in San Antonio?
Dr. Cabrera's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cabrera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in San Antonio
Browse nephrologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in TX
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in TX
Which TX nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Fresenius USA Marketing, Inc. Payments to Doctors
See all physicians who received payments from Fresenius USA Marketing, Inc.
By company
OPKO Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from OPKO Pharmaceuticals, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology